Grifols and Haier Group form strategic alliance for Chinese plasma market

Grifols announced a strategic alliance with Haier Group, selling approximately a 20% equity stake in Shanghai RAAS to Haier for RMB 12.5 billion (approximately USD 1.8 billion) to develop the Chinese plasma market.

“The alliance, through Shanghai RAAS (SRAAS), will drive synergies combining Grifols’ expertise and capabilities in pharmaceutical solutions and diagnostic with Haier’s innovative technology to strengthen and enhance China’s healthcare system.”grifols.com

• 1 source
• grifols.comGrifols reaches strategic alliance with Haier Group and raises approximately USD 1.8 billionDec 29, 2023

Summarized from public sources; check the original articles before acting on it.